Immune Responses to Two Dose Varivax +/- MMR-II

NCT00258726 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

105

Enrollment

NIH

Sponsor class

Conditions

Measles
Mumps
Rubella
Varicella

Interventions

BIOLOGICAL: MMR-II
BIOLOGICAL: Pro-Quad
BIOLOGICAL: Varivax

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)